TrialFrontiers in immunology2024

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10-60 years in China.

Zhenzhen Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.